Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Laxmi DentalNSE:LAXMIDENTL -0.58%19 EV-to-EBIT is 31.08 as of Aug. 18, 2026, which is 38% below its 10-year median of 50.25. GuruFocus rates NSE:LAXMIDENTL with a GF Score™ of 19/100. The stock has 4 warning signs investors should review. Among 471 Medical Devices & Instruments companies, Laxmi Dental ranks worse than 73.25% on this metric.
The historical rank and industry rank for Laxmi Dental's EV-to-EBIT or its related term are showing as below:
NSE:LAXMIDENTL'
s EV-to-EBIT Range Over the Past 10 Years
Min: 29.81 Med: 50.25 Max: 94.34
Current: 31.08
During the past 5 years, the highest EV-to-EBIT of Laxmi Dental was 94.34. The lowest was 29.81. And the median was 50.25.
NSE:LAXMIDENTL's EV-to-EBIT is ranked worse than 73.25% of 471
companies
in the Medical Devices & Instruments industry
Industry Median: 19.14
vs NSE:LAXMIDENTL: 31.08
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Laxmi Dental's Enterprise Value for the quarter that ended in Jun. 2026 was ₹12,368 Mil.
Laxmi Dental's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹326 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Laxmi Dental EV-to-EBIT Related Terms
Laxmi Dental EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Laxmi Dental's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:LAXMIDENTL vs ISRG, BDX, MDLN: EV-to-EBIT Comparison
For the Medical Instruments & Supplies subindustry, Laxmi Dental's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Laxmi Dental EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Laxmi Dental's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Laxmi Dental's EV-to-EBIT falls into.
Laxmi Dental's current Enterprise Value is ₹10,125 Mil.
Laxmi Dental's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹326 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Laxmi Dental (NSE:LAXMIDENTL) has a EV-to-EBIT of 31.08 as of Aug. 18, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Laxmi Dental and its competitors. This is 38% below median its historical median of 50.25. Over the past decade, Laxmi Dental's EV-to-EBIT has ranged from 29.81 to 94.34. According to the industry distribution chart, Laxmi Dental ranks #345 out of 471 companies in the Medical Devices & Instruments industry, placing it in the top 73.2%.
Is Laxmi Dental's EV-to-EBIT too high?
Laxmi Dental's current EV-to-EBIT of 31.08 is 38% below median its 10-year median of 50.25. Over the past 10 years, this metric has ranged from a low of 29.81 to a high of 94.34. The Medical Devices & Instruments industry median EV-to-EBIT is 19.14. Laxmi Dental's value of 31.08 is 62.4% above this industry median. Based on the distribution chart, Laxmi Dental ranks #345 out of 471 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Laxmi Dental has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Laxmi Dental's EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Laxmi Dental ranks #345 out of 471 companies for EV-to-EBIT. This places Laxmi Dental in the lower half of its industry. The industry median EV-to-EBIT is 19.14. Laxmi Dental's value of 31.08 is 62.4% above this benchmark. Historically, Laxmi Dental's own EV-to-EBIT has ranged from 29.81 to 94.34 over the past decade. While the company's 10-year median is 50.25 vs. the industry median of 19.14, Laxmi Dental has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 19.14, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Laxmi Dental's current EV-to-EBIT of 31.08 is 62.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Laxmi Dental and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 19.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Laxmi Dental's current EV-to-EBIT is 31.08, which is 38% below median its own 10-year median of 50.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laxmi Dental stock overvalued right now?
Laxmi Dental (NSE:LAXMIDENTL) has a current EV-to-EBIT of 31.08. The current EV-to-EBIT is 31.08, which is 38% below median its 10-year median of 50.25 and 62.4% above the Medical Devices & Instruments industry median of 19.14. Laxmi Dental's overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Laxmi Dental (NSE:LAXMIDENTL), the current EV-to-EBIT is 31.08 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Laxmi Dental Ltd is an end-to-end integrated dental products company. Its products include custom-made crowns and bridges, branded dental products such as clear aligners, thermoforming sheets, and aligner-related products as a part of aligner solutions, and paediatric dental products. The Group has three reportable segments: Laboratory Business segment comprises dental prostheses, such as metal-free crowns & bridges, Porcelain Fused to Metal (PFM) Crowns and Bridges, and Dentures. The Aligners Business segment comprises dental aligners, Retainers, Raw Materials for Aligners, Sport Guards, Night Guards, and Sleep Apnea Devices. The Other Business segment comprises Dental distribution products used in Dental Laboratory, Dental Clinical Services, and Dental Educational Courses.
19GF Score
Get the complete analysis for NSE:LAXMIDENTL
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:LAXMIDENTL has been successfully added to your 
